JP Morgan Chase
LUNG icon

JP Morgan Chase’s Pulmonx LUNG Stock Holding History

JP Morgan Chase’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-99,300
Closed -$2.46M – 6699
2022
Q1 		$2.46M Buy
+99,300
New +$2.56M ﹤0.01% 3598

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

JP Morgan Chase's LUNG Position: Q2 2026 in Review

JP Morgan Chase reduced its Pulmonx (LUNG) stake by 99% in Q2 2026, selling an estimated $532K and leaving 2,250 shares worth $2.99K. The position accounts for ﹤0.01% of the portfolio, ranked #7159.

JP Morgan Chase first reported a position in LUNG in Q4 2020 and has held it in 23 quarters since. The position peaked at $8.75M in Q3 2024. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • JP Morgan Chase held 2,250 shares of Pulmonx worth $2.99K as of Q2 2026.
  • JP Morgan Chase sold 385,853 Pulmonx shares in Q2 2026, an estimated $532K.
  • Pulmonx made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7159 holding.
  • JP Morgan Chase first reported a position in Pulmonx in Q4 2020 and has held it in 23 quarters since.
  • JP Morgan Chase's Pulmonx position peaked at $8.75M in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.